Russian Cardiology Research and Production Center
11
2
3
5
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 50/100
9.1%
1 terminated/withdrawn out of 11 trials
83.3%
-3.2% vs industry average
27%
3 trials in Phase 3/4
0%
0 of 5 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (11)
Russian Extreme Hypertriglyceridemia Registry
Role: lead
Features of the Clinical Course and Prognosis in Patients With Idiopathic Pulmonary Hypertension When Using Modern Strategies of Specific Therapy
Role: lead
Russian Familial Hypercholesterolemia Registry
Role: lead
RUS-registry of PH
Role: lead
Cardiovascular Epidemiology in Russian Federation
Role: collaborator
Studies Investigating Co-morbidities Aggravating Heart Failure
Role: collaborator
Aggressive Medical Treatment Evaluation for Asymptomatic Carotid Artery Stenosis
Role: lead
Prospective Russian Evaluation of Lp(a) Role in cardiovascUlar DiseasE
Role: lead
Specific Lp(a) Apheresis for Regression of Coronary and Carotid Atherosclerosis
Role: lead
Russian Study of the Effect of Continuous Positive Airway Pressure (CPAP) in Hypertension
Role: lead
Risk Factors of Hypertensive Urgencies
Role: lead
All 11 trials loaded